A detailed history of Susquehanna Fundamental Investments, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 201,671 shares of TXG stock, worth $3.26 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
201,671
Previous 75,619 166.69%
Holding current value
$3.26 Million
Previous $2.84 Billion 38.21%
% of portfolio
0.09%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$19.45 - $37.37 $2.45 Million - $4.71 Million
126,052 Added 166.69%
201,671 $3.92 Billion
Q1 2024

May 07, 2024

BUY
$36.08 - $54.3 $2.73 Million - $4.11 Million
75,619 New
75,619 $2.84 Billion

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.